280 related articles for article (PubMed ID: 18853416)
1. Neuroendocrine tumor epidemiology: contrasting Norway and North America.
Hauso O; Gustafsson BI; Kidd M; Waldum HL; Drozdov I; Chan AK; Modlin IM
Cancer; 2008 Nov; 113(10):2655-64. PubMed ID: 18853416
[TBL] [Abstract][Full Text] [Related]
2. Charting the Course: Insights into Neuroendocrine Tumor Dynamics in the United States.
Wu C; Song Z; Balachandra S; Dream S; Chen H; Rose JB; Bhatia S; Gillis A
Ann Surg; 2024 May; ():. PubMed ID: 38708616
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of quality of clinical management of neuroendocrine tumors.
Bloemen H; Kneepkens K; Deraedt K; Ivanova A; Sergeant G; Mebis J; Van der Speeten K
Cancer Innov; 2022 Dec; 1(4):305-315. PubMed ID: 38089084
[TBL] [Abstract][Full Text] [Related]
4. The epidemiology of gastroenteropancreatic neuroendocrine tumors.
Lawrence B; Gustafsson BI; Chan A; Svejda B; Kidd M; Modlin IM
Endocrinol Metab Clin North Am; 2011 Mar; 40(1):1-18, vii. PubMed ID: 21349409
[TBL] [Abstract][Full Text] [Related]
5. Trends in the Incidence, Prevalence, and Survival Outcomes in Patients With Neuroendocrine Tumors in the United States.
Dasari A; Shen C; Halperin D; Zhao B; Zhou S; Xu Y; Shih T; Yao JC
JAMA Oncol; 2017 Oct; 3(10):1335-1342. PubMed ID: 28448665
[TBL] [Abstract][Full Text] [Related]
6. ENETS Consensus Guidelines Update for Gastroduodenal Neuroendocrine Neoplasms.
Delle Fave G; O'Toole D; Sundin A; Taal B; Ferolla P; Ramage JK; Ferone D; Ito T; Weber W; Zheng-Pei Z; De Herder WW; Pascher A; Ruszniewski P;
Neuroendocrinology; 2016; 103(2):119-24. PubMed ID: 26784901
[No Abstract] [Full Text] [Related]
7. ENETS Consensus Guidelines Update for the Management of Distant Metastatic Disease of Intestinal, Pancreatic, Bronchial Neuroendocrine Neoplasms (NEN) and NEN of Unknown Primary Site.
Pavel M; O'Toole D; Costa F; Capdevila J; Gross D; Kianmanesh R; Krenning E; Knigge U; Salazar R; Pape UF; Öberg K;
Neuroendocrinology; 2016; 103(2):172-85. PubMed ID: 26731013
[No Abstract] [Full Text] [Related]
8. Exploring the rising incidence of neuroendocrine tumors: a population-based analysis of epidemiology, metastatic presentation, and outcomes.
Hallet J; Law CH; Cukier M; Saskin R; Liu N; Singh S
Cancer; 2015 Feb; 121(4):589-97. PubMed ID: 25312765
[TBL] [Abstract][Full Text] [Related]
9. ENETS 2016 Consensus Guidelines for the Management of Patients with Digestive Neuroendocrine Tumors: An Update.
O'Toole D; Kianmanesh R; Caplin M
Neuroendocrinology; 2016; 103(2):117-8. PubMed ID: 26731186
[No Abstract] [Full Text] [Related]
10. Incidence, patterns of care and prognostic factors for outcome of gastroenteropancreatic neuroendocrine tumors (GEP-NETs): results from the National Cancer Registry of Spain (RGETNE).
Garcia-Carbonero R; Capdevila J; Crespo-Herrero G; Díaz-Pérez JA; Martínez Del Prado MP; Alonso Orduña V; Sevilla-García I; Villabona-Artero C; Beguiristain-Gómez A; Llanos-Muñoz M; Marazuela M; Alvarez-Escola C; Castellano D; Vilar E; Jiménez-Fonseca P; Teulé A; Sastre-Valera J; Benavent-Viñuelas M; Monleon A; Salazar R
Ann Oncol; 2010 Sep; 21(9):1794-1803. PubMed ID: 20139156
[TBL] [Abstract][Full Text] [Related]
11. Recent updates on grading and classification of neuroendocrine tumors.
Kim JY; Hong SM; Ro JY
Ann Diagn Pathol; 2017 Aug; 29():11-16. PubMed ID: 28807335
[TBL] [Abstract][Full Text] [Related]
12. Placebo-controlled, double-blind, prospective, randomized study on the effect of octreotide LAR in the control of tumor growth in patients with metastatic neuroendocrine midgut tumors: a report from the PROMID Study Group.
Rinke A; Müller HH; Schade-Brittinger C; Klose KJ; Barth P; Wied M; Mayer C; Aminossadati B; Pape UF; Bläker M; Harder J; Arnold C; Gress T; Arnold R;
J Clin Oncol; 2009 Oct; 27(28):4656-63. PubMed ID: 19704057
[TBL] [Abstract][Full Text] [Related]
13. Everolimus plus octreotide long-acting repeatable for the treatment of advanced neuroendocrine tumours associated with carcinoid syndrome (RADIANT-2): a randomised, placebo-controlled, phase 3 study.
Pavel ME; Hainsworth JD; Baudin E; Peeters M; Hörsch D; Winkler RE; Klimovsky J; Lebwohl D; Jehl V; Wolin EM; Öberg K; Van Cutsem E; Yao JC;
Lancet; 2011 Dec; 378(9808):2005-2012. PubMed ID: 22119496
[TBL] [Abstract][Full Text] [Related]
14. Cat scratch disease in Connecticut. Epidemiology, risk factors, and evaluation of a new diagnostic test.
Zangwill KM; Hamilton DH; Perkins BA; Regnery RL; Plikaytis BD; Hadler JL; Cartter ML; Wenger JD
N Engl J Med; 1993 Jul; 329(1):8-13. PubMed ID: 8505963
[TBL] [Abstract][Full Text] [Related]
15. Consensus guidelines for the management and treatment of neuroendocrine tumors.
Kunz PL; Reidy-Lagunes D; Anthony LB; Bertino EM; Brendtro K; Chan JA; Chen H; Jensen RT; Kim MK; Klimstra DS; Kulke MH; Liu EH; Metz DC; Phan AT; Sippel RS; Strosberg JR; Yao JC;
Pancreas; 2013 May; 42(4):557-77. PubMed ID: 23591432
[TBL] [Abstract][Full Text] [Related]
16. The pathologic classification of neuroendocrine tumors: a review of nomenclature, grading, and staging systems.
Klimstra DS; Modlin IR; Coppola D; Lloyd RV; Suster S
Pancreas; 2010 Aug; 39(6):707-12. PubMed ID: 20664470
[TBL] [Abstract][Full Text] [Related]
17. ENETS Consensus Guidelines Update for Neuroendocrine Neoplasms of the Jejunum and Ileum.
Niederle B; Pape UF; Costa F; Gross D; Kelestimur F; Knigge U; Öberg K; Pavel M; Perren A; Toumpanakis C; O'Connor J; O'Toole D; Krenning E; Reed N; Kianmanesh R;
Neuroendocrinology; 2016; 103(2):125-38. PubMed ID: 26758972
[No Abstract] [Full Text] [Related]
18. ENETS Consensus Guidelines Update for the Management of Patients with Functional Pancreatic Neuroendocrine Tumors and Non-Functional Pancreatic Neuroendocrine Tumors.
Falconi M; Eriksson B; Kaltsas G; Bartsch DK; Capdevila J; Caplin M; Kos-Kudla B; Kwekkeboom D; Rindi G; Klöppel G; Reed N; Kianmanesh R; Jensen RT;
Neuroendocrinology; 2016; 103(2):153-71. PubMed ID: 26742109
[No Abstract] [Full Text] [Related]
19. ENETS Consensus Guidelines for High-Grade Gastroenteropancreatic Neuroendocrine Tumors and Neuroendocrine Carcinomas.
Garcia-Carbonero R; Sorbye H; Baudin E; Raymond E; Wiedenmann B; Niederle B; Sedlackova E; Toumpanakis C; Anlauf M; Cwikla JB; Caplin M; O'Toole D; Perren A;
Neuroendocrinology; 2016; 103(2):186-94. PubMed ID: 26731334
[No Abstract] [Full Text] [Related]
20. Current Trends of the Incidence and Pathological Diagnosis of Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs) in Korea 2000-2009: Multicenter Study.
; Cho MY; Kim JM; Sohn JH; Kim MJ; Kim KM; Kim WH; Kim H; Kook MC; Park DY; Lee JH; Chang H; Jung ES; Kim HK; Jin SY; Choi JH; Gu MJ; Kim S; Kang MS; Cho CH; Park MI; Kang YK; Kim YW; Yoon SO; Bae HI; Joo M; Moon WS; Kang DY; Chang SJ
Cancer Res Treat; 2012 Sep; 44(3):157-65. PubMed ID: 23091441
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
